The abstract is read at the publisher; the summary is JClub's.
An interactive HIV-1 Mutation Rate Atlas (MRA) built from error-corrected single-cycle data shows mutation-rate biases predict drug resistance variant frequencies across patients.
- Why it matters: Durable HIV-1 therapies require knowing not only which mutations resist drugs, but also how readily those mutations arise; mutational bias has been largely unquantified.
- What they did: The MRA uses empirical single-cycle HIV-1 mutation accumulation measurements without selection pressure, from error-corrected long-read sequencing, to estimate mutation rates at each genomic position to each nucleotide.
- The result: Across patients, amino-acid mutability derived from the MRA is linked to observed drug resistance variant frequencies, enabling prediction of HIV-1 evolutionary outcomes and resistance patterns.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.